• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声造影在肝细胞癌中的诊断价值:一项基于1998年至2016年证据的Meta分析

Diagnostic value of contrast-enhanced ultrasound in hepatocellular carcinoma: a meta-analysis with evidence from 1998 to 2016.

作者信息

Zhang Juanjuan, Yu Yanyan, Li Ying, Wei Lunshou

机构信息

Department of Ultrasound, Huaihe Hospital of Henan University, Kaifeng, China.

Department of Gastroenterology, Huaihe Hospital of Henan University, Kaifeng, China.

出版信息

Oncotarget. 2017 Aug 7;8(43):75418-75426. doi: 10.18632/oncotarget.20049. eCollection 2017 Sep 26.

DOI:10.18632/oncotarget.20049
PMID:29088877
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5650432/
Abstract

BACKGROUND

This meta-analysis is aimed at determining the diagnostic value of hepatocellular carcinoma (HCC) with contrast-enhanced ultrasound (CEUS).

MATERIALS AND METHODS

A comprehensive literature search of Pubmed, Web of Science, and the Cochrane Library was performed to identify published studies. The methodological quality of the included studies was evaluated. Data from eligible studies were used to estimate the pooled sensitivity, specificity, diagnostic odds ratio (DOR), positive and negative likelihood ratio (LR) and summary receiver operating characteristic (SROC) curve. Meta-Disc and STATA softwares were utilized for all statistical analyses.

RESULTS

Fifty-three eligible studies (publication years ranged from 1998 to 2016) were selected according to inclusion criteria. The meta-analysis showed that the pooled sensitivity and specificity of CEUS to detect HCC were 0.85 (95% CI: 0.84-0.86) and 0.91 (95% CI: 0.90-0.92), respectively. The pooled positive and negative LRs were 6.28 (95% CI: 4.49-8.77) and 0.16 (95% CI: 0.12-0.22), respectively. The pooled DOR was 55.01 (95% CI: 35.25-83.47). The area under the SCOR curve was 0.9432. Meta-regression and funnel plot indicated that sample size, type of contrast agents and publication bias might be the major sources of heterogeneity.

CONCLUSIONS

CEUS is a valuable diagnostic tool for identifying HCC in clinic with highly sensitive and specific.

摘要

背景

本荟萃分析旨在确定超声造影(CEUS)对肝细胞癌(HCC)的诊断价值。

材料与方法

全面检索了PubMed、科学网和考克兰图书馆,以识别已发表的研究。对纳入研究的方法学质量进行了评估。来自符合条件研究的数据用于估计合并敏感度、特异度、诊断比值比(DOR)、阳性和阴性似然比(LR)以及汇总受试者工作特征(SROC)曲线。所有统计分析均使用Meta-Disc和STATA软件。

结果

根据纳入标准,选择了53项符合条件的研究(发表年份从1998年至2016年)。荟萃分析显示,CEUS检测HCC的合并敏感度和特异度分别为0.85(95%CI:0.84 - 0.86)和0.91(95%CI:0.90 - 0.92)。合并阳性和阴性似然比分别为6.28(95%CI:4.49 - 8.77)和0.16(95%CI:0.12 - 0.22)。合并DOR为55.01(95%CI:35.25 - 83.47)。SROC曲线下面积为0.9432。Meta回归和漏斗图表明,样本量、造影剂类型和发表偏倚可能是异质性的主要来源。

结论

CEUS是临床上用于识别HCC的一种有价值的诊断工具,具有高度的敏感性和特异性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bd1/5650432/e25f561ade69/oncotarget-08-75418-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bd1/5650432/30c3e5daeead/oncotarget-08-75418-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bd1/5650432/94464d7879fd/oncotarget-08-75418-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bd1/5650432/0dea927e3bf3/oncotarget-08-75418-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bd1/5650432/969dbfbfd46f/oncotarget-08-75418-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bd1/5650432/e25f561ade69/oncotarget-08-75418-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bd1/5650432/30c3e5daeead/oncotarget-08-75418-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bd1/5650432/94464d7879fd/oncotarget-08-75418-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bd1/5650432/0dea927e3bf3/oncotarget-08-75418-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bd1/5650432/969dbfbfd46f/oncotarget-08-75418-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bd1/5650432/e25f561ade69/oncotarget-08-75418-g005.jpg

相似文献

1
Diagnostic value of contrast-enhanced ultrasound in hepatocellular carcinoma: a meta-analysis with evidence from 1998 to 2016.超声造影在肝细胞癌中的诊断价值:一项基于1998年至2016年证据的Meta分析
Oncotarget. 2017 Aug 7;8(43):75418-75426. doi: 10.18632/oncotarget.20049. eCollection 2017 Sep 26.
2
A meta-analysis of contrast-enhanced ultrasound for small hepatocellular carcinoma diagnosis.超声造影诊断小肝细胞癌的Meta分析
J Cancer Res Ther. 2016 Dec;12(Supplement):C274-C276. doi: 10.4103/0973-1482.200756.
3
Contrast-enhanced ultrasonography for the diagnosis of small hepatocellular carcinoma: a meta-analysis and meta-regression analysis.超声造影诊断小肝细胞癌的Meta分析及Meta回归分析
Tumour Biol. 2013 Dec;34(6):3667-74. doi: 10.1007/s13277-013-0948-z. Epub 2013 Jun 27.
4
Diagnostic value of liver contrast-enhanced ultrasound in early hepatocellular carcinoma: a systematic review and meta-analysis.肝脏超声造影在早期肝细胞癌中的诊断价值:一项系统评价和Meta分析
J Gastrointest Oncol. 2023 Apr 29;14(2):626-635. doi: 10.21037/jgo-23-211. Epub 2023 Apr 24.
5
Diagnostic accuracy of contrast-enhanced ultrasound for renal cell carcinoma: a meta-analysis.超声造影对肾细胞癌的诊断准确性:一项荟萃分析。
Tumour Biol. 2014 Jul;35(7):6343-50. doi: 10.1007/s13277-014-1815-2.
6
Differentiation between hepatocellular carcinoma and intrahepatic cholangiocarcinoma using contrast-enhanced ultrasound: A systematic review and meta-analysis.使用超声造影鉴别肝细胞癌和肝内胆管细胞癌:系统评价和荟萃分析。
Clin Hemorheol Microcirc. 2021;79(2):293-309. doi: 10.3233/CH-211145.
7
Contrast-enhanced ultrasound in the diagnosis of endometrial carcinoma: A meta-analysis.超声造影在子宫内膜癌诊断中的应用:一项荟萃分析。
Exp Ther Med. 2018 Dec;16(6):5310-5314. doi: 10.3892/etm.2018.6889. Epub 2018 Oct 22.
8
Role of contrast-enhanced ultrasound for differentiation of benign vs. malignant portal vein thrombosis in hepatocellular carcinoma - A systematic review a meta-analysis.超声造影在肝细胞癌门静脉血栓良恶性鉴别中的作用——一项系统评价与荟萃分析
Australas J Ultrasound Med. 2023 Dec 10;27(1):56-64. doi: 10.1002/ajum.12375. eCollection 2024 Feb.
9
Detection of Carotid Atherosclerotic Plaque Neovascularization Using Contrast Enhanced Ultrasound: A Systematic Review and Meta-Analysis of Diagnostic Accuracy Studies.使用对比增强超声检测颈动脉粥样硬化斑块新生血管:诊断准确性研究的系统评价和荟萃分析
J Am Soc Echocardiogr. 2016 Jun;29(6):491-502. doi: 10.1016/j.echo.2016.02.012. Epub 2016 Mar 30.
10
Meta-analysis of the diagnostic value of contrast-enhanced ultrasound for the detection of vascular complications after liver transplantation.对比增强超声对肝移植后血管并发症检测的诊断价值的荟萃分析。
Rev Esp Enferm Dig. 2019 May;111(5):388-396. doi: 10.17235/reed.2018.5818/2018.

引用本文的文献

1
Diagnostic performance of AI-based models versus physicians among patients with hepatocellular carcinoma: a systematic review and meta-analysis.基于人工智能的模型与医生对肝细胞癌患者的诊断性能:一项系统评价和荟萃分析
Front Artif Intell. 2024 Aug 19;7:1398205. doi: 10.3389/frai.2024.1398205. eCollection 2024.
2
Motion correction of 3D dynamic contrast-enhanced ultrasound imaging without anatomical B-Mode images: Pilot evaluation in eight patients.无解剖 B 型模式图像的 3D 动态对比增强超声成像的运动校正:在 8 例患者中的初步评估。
Med Phys. 2024 Jul;51(7):4827-4837. doi: 10.1002/mp.16995. Epub 2024 Feb 20.
3
Challenges and Solutions in the Management of Hepatocellular Carcinoma Associated with Non-Alcoholic Fatty Liver Disease.

本文引用的文献

1
Comparison of Contrast-Enhanced Ultrasound and Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI for the Diagnosis of Macroscopic Type of Hepatocellular Carcinoma.超声造影与钆贝葡胺增强MRI对巨块型肝细胞癌诊断的比较
Dig Dis. 2016;34(6):679-686. doi: 10.1159/000448855. Epub 2016 Oct 17.
2
LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.肝脏影像报告和数据系统-超声造影 - 关于高危人群肝细胞癌诊断的超声造影算法提案
Ultraschall Med. 2016 Dec;37(6):627-634. doi: 10.1055/s-0042-112221. Epub 2016 Aug 3.
3
非酒精性脂肪性肝病相关肝细胞癌管理中的挑战与解决方案
Life (Basel). 2023 Sep 29;13(10):1987. doi: 10.3390/life13101987.
4
Radiological Diagnosis of Chronic Liver Disease and Hepatocellular Carcinoma: A Review.慢性肝病和肝细胞癌的放射学诊断:综述。
J Med Syst. 2023 Jul 11;47(1):73. doi: 10.1007/s10916-023-01968-7.
5
Hematoma Disguised as Cancer.伪装成癌症的血肿
Cureus. 2023 May 29;15(5):e39665. doi: 10.7759/cureus.39665. eCollection 2023 May.
6
Clinical value of contrast-enhanced ultrasound in early diagnosis of small hepatocellular carcinoma (≤ 2 cm).超声造影在小肝癌(≤2cm)早期诊断中的临床价值
World J Clin Cases. 2022 Aug 26;10(24):8525-8534. doi: 10.12998/wjcc.v10.i24.8525.
7
Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.对比增强超声在慢性肝病成人肝细胞癌诊断中的应用。
Cochrane Database Syst Rev. 2022 Sep 2;9(9):CD013483. doi: 10.1002/14651858.CD013483.pub2.
8
Surveillance of hepatocellular carcinoma in cirrhotic patients: Current knowledge and future directions.肝硬化患者肝细胞癌的监测:当前认知与未来方向。
Hepatol Forum. 2020 Sep 21;1(3):112-118. doi: 10.14744/hf.2020.2020.0003. eCollection 2020 Sep.
9
Consensus on the secondary prevention of primary liver cancer.原发性肝癌二级预防共识。
Hepatol Int. 2021 Dec;15(6):1289-1300. doi: 10.1007/s12072-021-10259-7. Epub 2021 Nov 30.
10
Diagnostic role of contrast-enhanced ultrasonography versus conventional B-mode ultrasonography in cirrhotic patients with early hepatocellular carcinoma: a retrospective study.超声造影与传统B超在肝硬化合并早期肝细胞癌患者中的诊断价值:一项回顾性研究
J Gastrointest Oncol. 2021 Oct;12(5):2403-2411. doi: 10.21037/jgo-21-611.
Liver imaging reporting and data system (LI-RADS) version 2014: understanding and application of the diagnostic algorithm.
肝脏影像报告和数据系统(LI-RADS)2014版:诊断算法的理解与应用
Clin Mol Hepatol. 2016 Jun;22(2):296-307. doi: 10.3350/cmh.2016.0028.
4
Contrast-enhanced multiphase dynamic ultrasonography for the characterization of liver tumors.对比增强多期动态超声检查对肝脏肿瘤的特征性诊断
J Med Ultrason (2001). 2005 Jun;32(2):57-63. doi: 10.1007/s10396-005-0035-1.
5
A Milestone: Approval of CEUS for Diagnostic Liver Imaging in Adults and Children in the USA.一个里程碑:在美国,超声造影剂被批准用于成人和儿童肝脏诊断成像。
Ultraschall Med. 2016 Jun;37(3):229-32. doi: 10.1055/s-0042-107411. Epub 2016 Jun 8.
6
Parametric imaging with contrast-enhanced ultrasound for differentiating hepatocellular carcinoma from metastatic liver cancer.超声造影参数成像在鉴别肝细胞癌与肝转移癌中的应用
Clin Hemorheol Microcirc. 2016 Nov 25;64(2):177-188. doi: 10.3233/CH-162060.
7
Noninvasive Diagnosis of Hepatocellular Carcinoma: Elaboration on Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guidelines Compared with Other Guidelines and Remaining Issues.肝细胞癌的非侵入性诊断:韩国肝癌研究组-韩国国立癌症中心实践指南与其他指南的对比及遗留问题阐述
Korean J Radiol. 2016 Jan-Feb;17(1):7-24. doi: 10.3348/kjr.2016.17.1.7. Epub 2016 Jan 6.
8
Contrast-Enhanced Ultrasound for the Characterization of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.对比增强超声用于肝细胞癌和肝内胆管癌的特征性诊断
Liver Cancer. 2015 Dec;4(4):241-52. doi: 10.1159/000367738. Epub 2015 Oct 21.
9
Role of contrast-enhanced ultrasonography with Sonazoid for hepatocellular carcinoma: evidence from a 10-year experience.使用Sonazoid的超声造影在肝细胞癌中的作用:来自10年经验的证据
J Gastroenterol. 2016 May;51(5):421-33. doi: 10.1007/s00535-015-1151-3. Epub 2015 Dec 22.
10
Application of imaging fusion combining contrast-enhanced ultrasound and magnetic resonance imaging in detection of hepatic cellular carcinomas undetectable by conventional ultrasound.超声造影与磁共振成像融合成像在常规超声难以检测的肝细胞癌检测中的应用
J Gastroenterol Hepatol. 2016 Apr;31(4):822-8. doi: 10.1111/jgh.13202.